Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Intrance International AB
AB
In liquidation
Org 5592276132
Sundsvall
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Intrance International AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
JA
Jan Anders Fredrik Lovén
Liquidator
Liquidator
2025
AM
Anna Matilda Sjödin
External Signatory
External Signatory
2025
WL
Wendy Lissette Fahlgren
Liquidator
Liquidator
2025
Former (2)
BK
Birgitta Kristina O Lundvik
Chief Executive Officer
Chief Executive Officer
2021 – 2022
UL
Ulf Lennart Rosén
Chief Executive Officer
Chief Executive Officer
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Former (4)
JT
Jan Totte Dahlin
Board of Directors
2025 – 2025
PM
Patrick Michael Shea
Board of Directors
2022 – 2025
GU
Gerd Ulla Marina Jonsson
Deputy Board Member
2025 – 2025
FF
Fredrik Franz Johan W. Buch
Deputy Board Member
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Intrance International AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
